TickerSpark Feed

obesity drugs

Everything tagged "obesity drugs" across the TickerSpark archives.

Eli Lilly is turning obesity demand into an access story now

Eli Lilly's next move looks less like a pipeline trade and more like an access trade. Demand was never the problem; broader PBM coverage and expected Medicare access starting July 1 make the revenue conversion story more immediate.

Jun 28, 2026·4 MIN

Healthcare Obesity Drugs Medicare

Top Stocks

Top Obesity Drugs Stocks: Our 3 Picks for 2026

Lilly, Novo Nordisk, and Hims & Hers offer three different ways to invest in obesity drugs, with Lilly ranking highest on overall quality and execution.

May 30, 2026·8 MIN

obesity drugs

On-Demand Research

Need research on a stock not covered here?

Generate AI research on any ticker — grades, price targets, and full analysis in minutes.

Open the Generator

For Active Investors

Stock research for every investor

Reports on any stock
Daily market intelligence
AI analyst in your pocket
Portfolio analysis tools

Get Full Access →

Cancel anytime

Today's Top MoverPSTG

▲9.14%

Pure Storage Inc. · $86.22

Eli Lilly is turning obesity demand into an access story now

Top Obesity Drugs Stocks: Our 3 Picks for 2026

Need research on a stock not covered here?

A new stock idea, every evening.

Stock research for every investor